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Abstract  
Mobile devices, wearable technology, smartphone apps, and at home fitness tracking have 
becoming increasingly popular to monitor personal health. While cardiovascular diseases are 
the leading cause of mortality, these devices have become a part of people’s daily lives as 
they continuously collect health data to help users prevent and manage chronic diseases. 
Research has shown that increased arterial stiffness is positively correlated to increased risk 
of cardiovascular disease. The gold standard for measuring arterial stiffness is pulse wave 
velocity and is usually measured by SphygmoCor. Withings Body-Cardio scale is a new 
method in measuring pulse wave velocity and is a scale that an individual can use every day. 
This study is a validation test comparing the Withings scale to the gold standard method 
using the SphygmoCor. Subjects in this study had their body composition calculated on the 
BodPod and had it compared to the measurements by the Withings scale. Standing blood 
pressure was taken manually and with SphygmoCor. Heart rate and pulse wave velocity were 
measured by the SphygmoCor had it compared to the measurements taken by the Withings 
scale.  The results indicated that pulse wave velocity measurements taken by the two 
methods were not clinically different and that the Withings scale accurately calculates pulse 
wave velocity. This suggests individuals can use this scale daily to assess their cardiovascular 
health.  
Introduction 
Wearable devices and mobile phone health apps are becoming widely used among the public. 
According to the Intercontinental Marketing Services (IMS) Institute for Healthcare 
Informatics, there were around 110,000 mobile phone apps on Android and iPhone operating 
systems for health and fitness in 2015.12 The sales for wearable technology are projected to 
grow in the United States to $30 billion by 2018. These devices include Fitbit, Apple’s 
smartwatch, Jawbone, and Withings. Mobile devices have the capability to simultaneously 
collect data and have continuous access to personal health information which provides 
insights and a holistic view to individual health and fitness. As chronic disease is on the rise, 
these devices have integrated their existence into people’s daily routines and have become a 
part of normal life. Thus, these devices can be used as a great tool to manage or prevent 
chronic diseases by empowering users and educating them to take control of their health.1 
According to the World Health Organization, the leading causes of mortality in 
developed nations are cardiovascular diseases such as hypertension, coronary artery disease, 
stroke, and heart failure which are positively correlated to the stiffening of the central arterial 
system.9 However, majority of risk factors for these diseases are preventable and treatable 
with healthy lifestyle behaviors. When the heart contracts, it results in a propagated wave that 
interacts with aortic impedance which creates a low velocity pressure wave as it progresses to 
the capillaries.2,3 Elastic vasculature stiffening is associated with ageing, however, it is also 
related with cardiovascular and metabolic diseases where cellular mechanisms harden vessel 
walls. Decreased vascular compliance accentuates itself in a clinical setting as systolic 
hypertension where systolic blood pressure is greater than 140 mmHg and diastolic blood 
pressure is less than 90 mmHg.2 The aorta is less able to accommodate the blood volume 
ejected by the left ventricle exposing the myocardium to higher systolic pressure which can 
lead to left ventricular hypertrophy.3 
Mechanical properties of large arteries are important determinants of health. During 
the systolic part of blood flow, large elastic arteries absorb the energy which then reduces the 
cardiac work for the given cardiac output.4 Pulse wave velocity is the gold standard in 
measuring arterial stiffness and is usually measured by a SphygmoCor.5 It is considered the 
most precise way to non-invasively estimate arterial stiffness in humans. Measuring this is 
highly reproducible, accurate, and easily and automatically determined. It is used as an index 
of arterial distensibility: the ability of the artery to stretch. Faster speeds or a high pulse wave 
velocity indicate stiffer arteries which is associated with an increased risk in hypertension or 
cardiovascular disease. It is calculated from the distance the pulse travels between two 
recording sites and the time it takes for it to travel. The two recording sites commonly used 
are the carotid and femoral arteries.4 Carotid-femoral pulse wave velocity evaluate aortic 
distensibility because the pressure waveforms are easily recorded on these sites, the distance 
between them is large enough for an accurate calculation of time interval, and it reflects 
arterial wall elasticity which is related to the aorta. Reduced arterial distensibility leads to an 
increase in systolic pressure which is associated with cardiovascular morbidity. In humans, 
age is the most important contributing factor to increased pulse rate velocity because of 
increased arterial stiffness from reduced elasticity and medial calcification where calcium 
deposits are found in the middle muscular layer of the arteries which leads to the hardening 
of arteries.6 Stiffening of the arteries estimated by pulse wave velocity measurements helps 
early detection of vascular damage and individual cardiovascular risk. 
 A new method of calculating pulse wave velocity is via Withings’ Body-Cardio Scale 
which connects to the Health Mate app on a smart phone device.10 Unlike the SphygmoCor 
which requires a trained operator and is used in a medical setting, the Body-Cardio Scale can 
be used at home. It provides accessibility to the measurement of pulse wave velocity to the 
general population. The way that the scale does this is by measuring the time it takes for the 
blood that is ejected by the aorta to reach the feet. Because many factors can affect the 
variation of blood pressure and pulse wave velocity measurements such as time of day, stress 
level, diet, physical activity level, and coffee consumption, an individual will be able to 
estimate pulse wave velocity daily with the scale to get a more holistic picture of 
cardiovascular health.  
Methods 
Participants Five young adults participated in this study. Four subjects were male and one 
subject was female.  
Study Design Subjects reported to the Vascular Biology and Autonomic Studies lab in 
Charleston Forge for one visit that lasted approximately 60 minutes. The subjects were tested 
early in the morning, were fasted for at least 8 hours, and refrained from alcohol, caffeine and 
tobacco 24 hours prior to the visit. The study was approved by the University Institutional 
Review Board.  Subjects gave written informed consent and went through a medical history 
form before participation. 
  Height and weight of the subjects were measured and blood pressure was then 
measured standing up. Body fat percentage was measured next using the BodPod 
plethysmograph. The subject sat in the chamber while the BodPod estimated fat mass and 
muscle mass by air movement.  
The subject was registered on to the Withings Scale by using the Health Mate App to 
enter biometric data on an Apple iOS device. Once the biometric data was entered in, the 
subject moistened his or her feet before stepping on to the Withings Scale. Then, the subject 
stood on the scale until it recognized him or her and could calculate heart rate. The subject 
stood on the scale five times or until a pulse wave velocity measurement was detected.  
A standing blood pressure was then calculated with the SphygmoCor. After that, a 
cuff was placed on top of the thigh to constrict the femoral artery. Measurements were taken 
from the carotid artery to the sternal notch, from the sternal notch to the cuff, and the femoral 
artery to the cuff. A pen-like device was placed on the subject’s carotid artery and the 
SphygmoCor measured pulse wave velocity and heart rate. Directly after, the subject 
dampened his or her feet with a wet paper towel and stood on the Withings scale until a pulse 
wave velocity measurement was taken. Heart rate, fat mass, and fat free mass were also 
calculated by the Withings scale. A total of three trials were conducted.     
Results 
Statistical analyses were run for all samples through SPSS. Repeated measures anova was 
performed. Since several measures did not reach significance t-tests were employed and the 
results were plotted as box and whiskers to create visual representations of the data. 
 
Figure 1. Fat free mass percentage calculated with BodPod vs Withings scale  
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 BodPod fat free mass had a mean of 84.68 ± 9.74% and Withings fat free mass had a 
mean of 91.88 ± 4.52%. There was a significant difference between fat free mass measured 
with gold standard versus Withings scale where the Withings significantly overestimated fat 
free mass (*p = 0.037) 
 
Figure 2. Fat mass percentage calculated with BodPod vs Withings scale  
 BodPod fat mass had a mean of 15.32 ± 9.74% and Withings fat mass had a mean of 
8.11 ± 4.53%. There was a significant difference between fat mass measured with gold 
standard versus Withings scale where the Withings significantly underestimated fat mass (*p 
= 0.037) 
 
Figure 3. Body Mass Index calculated with BodPod vs Withings Scale  
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 The mean for BMI calculated with BodPod was 22.41 ± 1.89% and from Withings it 
was 22.5 ± 1.9%. There was a significant difference between BMI measured with gold 
standard versus Withings scale where the Withings slightly overestimated BMI (p = 0.004) 
 
 
Figure 4. Systolic blood pressure taken standing manually vs SphygmoCor 
    
 
Figure 5. Diastolic blood pressure taken standing manually vs SphygmoCor  
 
Figure 6. Heart rate calculated with SphygmoCor vs Withings scale  
 SphygmoCor heart rate mean was 68.07 ± 7.56 beats per minute and Withings heart 
rate mean was 72.73 ± 5.79 beats per minute. There was no significant difference between 
heart rate measured with gold standard versus Withings scale (p = 0.096).  
 
 
Figure 7. Pulse wave velocity calculated with SphygmoCor vs Withings scale  
 SphygmoCor pulse wave velocity mean was 6.31 ± 0.43 m/s and Withings pulse 
wave velocity mean was 5.9 ± 0.48 m/s. There was a significant difference between pulse 
wave velocity measured with gold standard versus Withings scale where the Withings 
slightly underestimated pulse wave velocity (p = 0.011) 
 
* 
Discussion 
The present study was a validity test comparing pulse wave velocity measurements with the 
Withings Body-Cardio scale to the SphygmoCor gold standard. The results suggest that there 
is significant different between body composition comparing the Withings scale to the 
BodPod gold standard. With a 7% fat mass and fat free mass difference between the means, 
the Withings scale is not reliable in measuring body composition as it significantly 
overestimates fat free mass and significantly underestimates fat mass. Withings uses 
Bioelectrical Impedance Analysis (BIA) to estimate body composition. The scale sends a 
small current to measure impedance that is used to calculate an estimate of total body of 
water which estimates body composition.11 However, a person’s hydration levels can affect 
BIA’s accuracy. BMI measurements between BodPod and the Withings scale had a 
significant difference where Withings slightly overestimated BMI. The height of the subject 
was measured by the stadiometer, however, the difference in BMI came from the different 
weight measurements calculated by BodPod and Withings. The results also show that there is 
no significant difference between heart rate calculated by the SphygmoCor gold standard and 
the Withings scale. This is important because an increase in heart rate is correlated with an 
increase in pulse wave velocity. Systolic and diastolic blood pressure was measured once 
manually standing up and three times by the SphygmoCor from the three trials and an 
average taken from the three trials. Research has shown that an increase in blood pressure has 
an increase in pulse wave velocity. The results for the subjects showed they had 
normotensive blood pressure which related to the pulse wave velocity results as those were in 
the normal range of 5.3 m/s – 7.1 m/s for ages less than 30 years. Pulse wave velocity 
measurements between the SphygmoCor gold standard and Withings scale had a significant 
difference with Withings slightly underestimating it. However, there is no clinical difference 
between the gold standard and the scale. This suggests that the Withings scale is reliable to 
accurately measure pulse wave velocity.   
 Arterial stiffness is the vessels’ first modification that leads to cardiovascular disease 
therefore consistently measuring pulse wave velocity can help with early detection of 
cardiovascular disease and to help maintain a healthy lifestyle. This study indicates that the 
Withings Body-Cardio scale can be used by individuals daily to measure pulse wave 
velocity. Individuals can use the scale at home without a trained professional and can get a 
pulse wave velocity measurement over time to best assess cardiovascular health. At home 
measurements are ideal because it reduces the white coat effect: blood pressure increases 
when obtained by a medical professional of authoritative standing. Research has shown that 
the effect specifically increases systolic blood pressure and is a common phenomenon 
conditioned by anticipation of having blood pressure taken with the fear that the results may 
indicate an illness.8  
There are few limitations in this study. One was the amount of time it took to get a 
pulse wave velocity measurement with the SphygmoCor. Because it took a long time 
detecting a pulse in the carotid artery, the tonometer depressed the artery. Thus, it became 
more difficult to get accurate pulse wave velocity measurement in the subsequent trials. The 
Withings scale also did not detect heart rate and pulse wave velocity consistently. There were 
only five subjects so the sample size was small which questions the stability of the statistics. 
In future studies, a bigger age range should be introduced to provide more variability in the 
results instead of in the normal range with healthy young adults.   
In conclusion, the Withings Body-Cardio scale is a valid way of measuring pulse 
wave velocity in healthy young adults and can be used instead of the SphygmoCor. It is 
affordable and can provide an overall assessment of cardiovascular health. 
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